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Copyright © 200? JCBN 200? This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. This study aimed to examine the association of dietary vitamin
intakes with plasma pro inflammatory cytokine levels in Korean
heart failure patients. Stable outpatients with heart failure were
recruited and finally 91 patients were included. Dietary intakes
were estimated by a developed semi quantitative food frequency
questionnaire. The simultaneous measurement of 17 cytokines was
performed along with analysis of plasma C reactive protein. Plasma
C reactive protein levels significantly correlated with dietary
intakes of vitamin C (r = −0.30,  p<0.005),  β carotene (r = −0.23,
p<0.05), and folate (r = −0.31, p<0.005). However, these associa 
tions were no longer significant after adjusting for traditional risk
factors for heart failure. On the other hand, plasma levels of
monocyte chemoattractant protein 1 significantly correlated with
dietary folate intake (r = −0.31, p<0.001), and plasma interleukin 8
levels significantly correlated with dietary intakes of vitamin C
(r = −0.38,  p<0.001),  β carotene (r = –0.42,  p<0.001), and folate
(r = −0.38,  p<0.001) after the adjustment. Dietary folate intake
was found as a primary influencing factor on plasma levels of
monocyte chemoattractant protein 1 (p<0.005, R2 = 0.20) and
interleukin 8 (p<0.001, R2 = 0.32) through a stepwise multiple
linear regression analysis. Dietary folate intake was significantly
associated with plasma levels of monocyte chemoattractant
protein 1 and interleukin 8 which indicates dietary folate may
have a potentially beneficial role in the prevention and treatment
of heart failure.
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Introduction Accumulating data have suggested that various cytokines play
important roles in the development and the progression of
heart failure (HF).(1) Monocyte activation in the myocardium under
conditions of myocardial injury is postulated to be associated
with the increased production of pro-inflammatory cytokines in
HF, which possibly affects cardiac remodeling and peripheral
disturbance.(2–5) It has been consistently reported that circulating
levels of tumor necrosis factor alpha (TNF-α) and interleukin
(IL)-6 are elevated in patients with HF,(6) and a direct relationship
between the levels of these cytokines and deteriorating functional
classes of HF.(7–8)
On the other hand, antioxidant vitamins are reported to
modulate pro-inflammatory pathways in numerous diseases.(9–11)
Antioxidant vitamins may protect against oxidant-mediated
inflammation and tissue damage by scavenging free radicals and
inhibiting oxidant-sensitive transcription factors.(7) Plasma levels
of antioxidant vitamins such as β-carotene, α-carotene and lyco-
pene are known to reflect dietary intake of these vitamins.(12–15)
Animal and in vitro studies also showed that dietary factors such
as antioxidants and fatty acids may modulate the expression of
pro-inflammatory cytokines.(8,16) Considering that micronutrient
deficiencies are very common in HF patients and potentially
contribute to the cause of HF,(8) the maintenance of adequate
antioxidant status may be useful in attenuating the cellular injury
and inflammatory dysfunction observed in HF. In line with this
evidence, a recent study suggested that long-term micronutrient
supplementation in elderly HF patients can improve left
ventricular function and quality of life.(17)
Taken together, certain dietary vitamins which have antioxidant
properties may be associated with levels of pro-inflammatory
cytokines, which can be an important factor for the pathogenesis
and the progression of HF. Therefore, the present study examined
the associations of antioxidant vitamin intakes from usual diet
with plasma levels of pro-inflammatory cytokines along with C-
reactive protein (CRP) as a surrogate inflammatory marker in
patients with HF.
Materials and Methods
Study subjects. Ninety-one eligible consecutive ambulatory
HF patients from an HF outpatient clinic at Yonsei Cardiovascular
Center participated in this cross-sectional study (Mar 2008–Oct
2008). The inclusion criteria were: (1) diagnosis of systolic HF
with a left ventricular ejection fraction (LVEF) ≤50%, (2) ≤80
years of age, and (3) stable HF through medication for at least 1
month prior to inclusion. We excluded patients with (1) a diagnosis
of HF with preserved ejection fraction (>50%), (2) a diagnosis of
acute myocardial infarction 3 months prior to inclusion, (3) severe
cognitive impairment and (4) antioxidant vitamin supplementation.
The patients were given written informed consent, and the Institu-
tional Review Board at Yonsei University Medical Center approved
the study protocol. Medical history, including diagnosis, underlying
disease, etiology of HF, and drug use, was obtained from the
hospital database.
Anthropometric parameters and blood collection. Body
weight and height were measured unclothed and without shoes in
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the morning. Body mass index (BMI) was calculated as body
weight in kilograms divided by height in square meters (kg/m2).
After overnight fast, venous blood specimens were collected in
EDTA-treated tubes (8 h–10 h). The collected samples were kept on
ice before being arrived at laboratory. Then, they were centrifuged
and separated into plasma and stored at −70°C until analysis of
plasma cytokines.
Survey for nutrient intakes. Dietary data were obtained by
a nutritionist using a semi-quantitative food-frequency question-
naire (FFQ) of which the validity had been previously tested.(18)
The questionnaire was composed of 87 food items commonly used
by Koreans. Each subject was asked to report the usual frequency
of consumption and usual portion size of the listed items during
the past year. Based on this information, nutrient intakes were
calculated from Korean food composition tables and other pub-
lished data.(19–21) The daily nutrient intakes were calculated by
multiplying the nutrient content of the specified portion of each
food item by the frequency of its daily consumption and summing
over all items. Average values of daily intakes of macronutrients
and vitamins of study subjects are presented in Table 1.
Plasma levels of CRP and proinflammatory cytokines.
Plasma CRP was measured by an Express Plus autoanalyzer
(Chiron Diagnostics Co., MA) using a commercially available
high-sensitivity kit, CRP-Latex (II) X2 (Seiken Laboratories Ltd.,
Tokyo, Japan). Plasma concentrations of IL-1β, IL-2, IL-4, IL-6,
IL-7, IL-8, IL-10, IL-12, IL-13, IL-17, granulocyte-colony stimu-
lating factor (G-CSF), granulocyte-macrophage (GM)-CSF,
interferon (IFN)-γ, macrophage migration inhibitory factor-1β
(MIP-1β), monocyte chemoattractant protein-1 (MCP-1), and
TNF-α were measured using a Bio-Plex human cytokine assay kit
(Bio-Rad Laboratories, Inc., Hercules, CA).
Statistical analysis. Statistical tests were performed with
SPSS 12.0 software package (Statistical Package for the Social
Science, SPSS Ins., Chicago, IL). Each variable was examined
for normal distribution and abnormally distributed variables
were log-transformed. The data are presented as the mean ± SD
The Pearson (unadjusted) and partial (adjusted for traditional risk
factors for HF) correlation analyses were used to evaluate the
relationship among variables. Stepwise multiple regression analysis
was used to determine which factor mainly contributes to plasma
levels of pro-inflammatory cytokines. p values less than 0.05 were
considered statistically significant.
Results
General characteristics of study subjects. Table 1 presents
the mean age (63.2 ± 11.6 years) and body mass index (BMI,
23.6 ± 3.7 kg/m2) of the 91 HF patients (60 males and 31 females).
Study subjects were in the New York Heart Association (NYHA)
functional classes I and II. The mean ejection fraction was
33.9 ± 10.1% in the total subjects. Twenty-seven patients had
diabetes mellitus and 32 patients had hypertension. The etiology
of HF included 56 by ischemic heart disease and 35 by non-
ischemic heart disease. Medical treatment for all subjects con-
sisted of diuretics (65.9%), digitalis (17.6%), β-blockers (60.4%),
angiotensin converting enzyme (ACE) inhibitors and/or angio-
tensin II receptor blockers (69.2%), and hypolipidemic agents
(53.8%). Table 1 also includes the information of daily nutrient
intakes of study subjects.
Correlations of antioxidant vitamin intakes with plasma
levels of CRP and inflammatory cytokines. Seventeen kinds
of cytokines in plasma were measured in this study. Among these
17 cytokines, those detected in more than 80% of the total samples
were used for further analysis. This included IL-1β, IL-5, IL-6,
IL-7, IL-8, IL-10, MCP-1, and MIP-1β. Correlation analysis
showed that dietary intake of vitamin C, β-carotene and folate
among reported vitamins were associated with plasma levels of
cytokines as follows. Plasma MCP-1 levels significantly correlated
with dietary intakes of vitamin C (r = −0.24, p<0.05) and folate
(r = −0.31, p<0.001). However, the significance maintained only
between MCP-1 and dietary folate intake after the adjustment for
traditional risk factors for HF (i.e. age, gender, BMI, smoking,
alcohol consumption, drug use, and the presence of disease) (r =
−0.28, p<0.01). On the other hand, plasma IL-8 levels signifi-
cantly correlated with dietary intakes of vitamin C (r = −0.34,
p<0.005), β-carotene (r = −0.38, p<0.001), and folate (r = −0.37,
p<0.001) before and after the adjustment for traditional risk factors
(vitamin C: r = −0.38, p<0.001, β-carotene: r = −0.42, p<0.001,
and folate: r = −0.38, p<0.001). In addition, plasma CRP levels
significantly correlated with dietary intakes of vitamin C (r = −0.30,
p<0.005), β-carotene (r = −0.23, p<0.05), and folate (r = −0.31,
p<0.005). However, these significances disappeared after the
adjustment.
Stepwise multiple regression analysis to find the major
contributors to plasma levels of MCP 1 and IL 8. Stepwise 
multiple linear regression analysis was used to determine the
independent influencing factors on plasma levels of MCP-1 and
IL-8. Independent variables included traditional risk factors for
HF (i.e. age, gender, BMI, smoking, alcohol consumption, drug
use, and the presence of disease), and all the dietary vitamins
which showed significant associations as shown in Table 2. The
analysis revealed that dietary folate intake was a primary influ-
encing factor on plasma levels of MCP-1 (adjusted β-coefficient:
−0.296,  p<0.005, R2 = 0.20) and IL-8 (adjusted β-coefficient:
−0.368,  p<0.001, R2 = 0.32). ACE inhibitor and hypertension
were found as secondary factors affecting MCP-1 (adjusted β-
coefficient: 0.213, p<0.05) and IL-8 (adjusted β-coefficient: −0.291,
p<0.01), respectively (Table 3).
Discussion
The aim of this study was to examine the relationships between
dietary intakes of antioxidant vitamins and the levels of pro-
inflammatory cytokines in Korean HF patients in a cross-sectional
Table 1. Baseline characteristics of the total subjects
Total subject (n =9 1 )
Age (years) 63.2 ± 11.6
Gender (M/F) 60/31
Body mass index (kg/m2) 23.6 ± 3.7
Waist circumferences (cm) 84.3 ± 10.4
Current smoker (%) 34 (37.4%)
Current alcohol consumer (%) 26 (28.6%)
Daily nutrient intakes
Total energy (kcal) 2013.9 ± 579.6
Carbohydrate (g) 291.8 ± 71.2
% Carbohydrate (% for kcal) 59.2 ± 8.2
Protein (g) 89.1 ± 32.7
% Protein (% for kcal) 17.5 ± 2.4
Fat (g) 57.4 ± 27.2
% Fat (% for kcal) 24.8 ± 5.8
Vitamin intake
Vitamin A (μg RE/d) 1125.4 ± 633.6
β carotene (mg/d) 5.2 ± 3.4
Vitamin D (μg/d) 60.5 ± 53.9
Vitamin E (mg α TE/d) 17.2 ± 6.6
Vitamin C (mg/d) 167.3 ± 78.1
Thiamin (mg/d) 1.6 ± 0.6
Riboflavin (mg/d) 1.5 ± 0.5
Niacin (mg NE/d) 18.2 ± 8.3
Vitamin B6 (mg/d) 2.6 ± 0.8
Folate (μg/d) 378.5 ± 126.9
Vitamin B12 (μg/d) 2.6 ± 2.3doi: 10.3164/jcbn.10 129
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setting. The results showed that dietary folate intake was found
an independent influencing factor on plasma levels of IL-8 and
MCP-1.
Several observational and clinical studies have reported that
low folate intake is associated with an increased risk of coronary
vascular disease and stroke.(22–24) A study conducted in German
reported a negative relationship of dietary folate intake with the
risk of myocardial infarction which suggested that folate intake
may be an important factor for the primary prevention of myo-
cardial infarction.(25) Regarding the association of dietary folate
with inflammation, a randomized placebo-controlled study showed
that folate supplementation for 12 weeks significantly decreased
the levels of IL-8, MCP-1, and CRP in overweight subjects.(26)
Furthermore, supplementation of folate and folate plus antioxidants
improved endothelial dysfunction estimated with branchial artery
flow-mediated dilation in coronary artery disease (CAD) patients,
by increasing plasma folate levels.(27) The relationship between
folate and pro-inflammatory cytokines is further supported by the
data from in vivo and experimental studies.(17,28) Six-month folate
treatment in hyperhomocysteinemic patients reduced the amounts
Fig. 1. Relationship between dietary folate intake and plasma levels of MCP 1or IL 8. φ: log transformed value, r0: Pearson correlation coefficient
(unadjusted), r2: Partial correlation coefficient (adjusted for traditional risk factors for heart failure: age, gender, body mass index, smoking, alcohol
consumption, drug use, and the presence of diseases). β': adjusted β coefficient, tested by stepwise multiple regression analysis [Independent
variable input: traditional risk factors for HF including age, gender, body mass index, smoking, alcohol consumption, drug use, and the presence of
diseases and dietary antioxidant vitamins intake (vitamin C, β carotene and folate)]. MCP 1: monocyte chemoattractant protein 1, IL 8: interleuking 8.
Table 2. Correlations between antioxidant vitamin intakes and plasma pro inflammatory cytokines in the total HF patients
Tested by Pearson and partial correlation analysis. r = correlation coefficient. r0: unadjusted, r1: after adjusting for traditional risk factors for HF
including age, gender, body mass index, smoking, alcohol consumption, drug use, and the presence of diseases. *p<0.05, **p<0.01, ***p<0.005,
****p<0.001. MCP 1: monocyte chemoattractant protein 1, IL 8: interleuking 8.
Vitamin C β carotene Folate
C reactive protein r0 −0.30*** −0.23* −0.31***
r1 ns ns ns
MCP 1 r0 −0.24* ns −0.31****
r1 ns ns −0.28**
IL 8 r0 −0.34*** −0.38**** −0.37****
r1 −0.38**** −0.42**** −0.38****
Table 3. Stepwise multiple regression to identify factors influencing plasma levels of MCP 1 and IL 8
Independent variable input: traditional risk factors for HF including age, gender, body mass index, smoking, alcohol consumption, drug use, and the
presence of diseases and dietary antioxidant vitamins intake (vitamin C, β carotene and folate); MCP 1: monocyte chemoattractant protein 1, IL 8:
interleuking 8, ACEI: angiotensin converting enzyme inhibitor, HTN: hypertension.
Dependent variable Independent variable Adjusted β coefficients p value R2 p value
MCP 1




Dietary folate −0.368 <0.001
0.32 <0.001
HTN 0.291 <0.01 J. Clin. Biochem. Nutr. | July 2011 | vol. 49 | no. 1 | 65
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of MCP-1 and IL-8 secreted by human monocytes.(17) Several
experimental and animal studies have also shown that folate
inhibits homocysteine-induced NF-κB activation and MCP-1
expression in macrophages.(28) The exact mechanism for the
beneficial effects of folate on inflammation has not been eluci-
dated, but several possible pathways could be involved. One
potential mechanism is associated with the ability of folate to
reduce homocysteine levels. Hyperhomocysteinemia is a predic-
tive risk marker of HF(29) and is associated with the severity of
HF.(30) Plasma homocysteine levels are strongly influenced by
folate, vitamin B12, and B6 and hyperhomocysteinemia might
increase the expression of adhesion molecule followed by the
immigration and activation of inflammatory cells and the secretion
of chemokines such as MCP-1 and IL-8.(31,32) Homocysteine
particularly induces the expression and secretion of MCP-1 and
IL-8 in human aortic endothelial cells, smooth muscle cell lines
and monocyte cell lines via the activation of NF-κB, which results
in the increased monocyte chemotaxin.(33–35) MCP-1 and IL-8 are
known to play an important role in the pathogenesis of HF.
MCP-1 stimulates the migration of monocytes into the intima of
arterial walls and serum IL-8 is also known as a predictor of HF
in patients with myocardial infarction. In fact, IL-8 and MCP-1 are
chemokine superfamily as chemotatic factor and have similar
structure: mature MCP-1 protein possesses four cysteines at
similar position as IL-8.(33) Thus, it is possible that dietary folate
reduces MCP-1 and IL-8 together by decreasing levels of homo-
cysteine which induces secretions of MCP-1 and IL-8 and that’s
why we could find the significant correlations especially with
IL-8 and MCP-1 in our HF subjects.
Alternatively, folate may have beneficial effects on endothelial
function as an antioxidant independent of its lowering of
homocysteine. Recently, in vitro evidence has indicated that
folate, as a potential antioxidant, can increase nitric oxide (NO)
production, directly scavenge superoxide radicals,(36,37) and inhibit
microsomal lipid peroxidation.(38) In addition, several studies
proposed that 5 methylene tetra-hydrofoalte (5MeTHF), the main
circulating metabolite of folate, directly influences endothelial
NO synthase (eNOS) activity by stabilizing tetrahydrobiopterin
(BH4), a cofactor of the eNOS reaction.(37,39) Therefore, it is
possible that folate may suppress pro-inflammatory cytokines
such as IL-8 and MCP-1 through its antioxidant potential and
ameliorate endothelial function in HF. In the present study, we
observed that dietary folate was an independent influencing factor
for the levels of IL-8 and MCP-1 among many inflammatory
markers. Chemokines, including IL-8 and MCP-1, have been
implicated in the pathogenesis of type 2 diabetes mellitus and
atherosclerosis,(40,41) in which they stimulate vascular endothelial
cells and the trafficking of macrophages into the arterial intima.
Considering that serum IL-8 was found to be a predictor of HF in
patients with myocardial infarction and percutaneous interven-
tion,(42) we can speculate that dietary folate might be associated
with the roles of chemokines in immunologic and inflammatory
processes in HF. With regard to the adequacy of dietary vitamin
intakes in the study subjects, the results showed that about 38%
of the total subjects had lower intakes than the dietary reference
intakes (DRIs) but, dietary folate intake met the DRIs for Koreans.
This indicates that the proportion of lower intakes of dietary
vitamin in HF patients was substantial, which could lead to
potential nutritional complications in these patients. Our observa-
tions support previous reports indicating that dietary folate intake
may be associated with the suppression of inflammatory cytokine
levels in HF. Furthermore, it can be suggested that a systemic
nutritional education program is especially needed for HF patients
as a preventive measure.
Still, however, this issue remains controversial. Several epide-
miological and intervention studies have failed to prove a relation-
ship between serum folate level and inflammatory markers.(43,44) It
was reported that folate supplementation did not improve inflam-
mation such as IL-6, IL-8, CRP, and MCP-1 despite lowering
homocysteine levels.(45,46) Further studies are needed to elucidate
the relationship between folate and pro-inflammatory cytokines in
various populations, thus explaining the discrepancy in results
across studies.
The present study has several limitations. First, we did not
measure plasma homocysteine levels, making it difficult to confirm
whether the effect of dietary folate on pro-inflammatory markers
is related to the reduction of homocysteine. Second, an examina-
tion of plasma folate levels is required to clarify folate status in the
body as well as dietary folate intake. Third, the cross-sectional
study design, small sample size, and use of an FFQ to assess
dietary intake are further limitations. Fourth, there was no control
group used to compare the levels of dietary vitamin intake and
pro-inflammatory markers. Nevertheless, the present study is
meaningful because it was conducted in a very homogenous group
of Korean subjects with controlled severity of HF.
Despite these limitations, the present study shows the inverse
relationship between dietary folate intake and plasma levels of
IL-8 and MCP-1 in HF patients. It may provide a better under-
standing of the potential anti-inflammatory effects of folate on
HF. As evidenced by a recent study showing that serum IL-8 is a
predictor of HF, the combined data suggest a major role of folate
in the immunologic and inflammatory processes of HF.
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ACE angiotensin converting enzyme
BH4 tetrahydrobiopterin
BMI body mass index
CAD coronary artery disease
CRP C-reactive protein
DRIs dietary reference intakes
FFQ food-frequency questionnaire
G-CSF granulocyte-colony stimulating factor




LVEF left ventricular ejection fraction
MCP-1 monocyte chemoattractant protein-1
5-MeTHF 5 methylene tetra-hydrofoalte
MIP-1β macrophage migration inhibitory factor-1β
NO nitric oxide
NOS NO synthase
NYHA New York Heart Association
TNF-α tumor necrosis factor alpha
References
1 Gullestad L, Aukrust P. The cytokine network in heart failure: pathogenetic
importance and potential therapeutic targets. Heart Fai Monit 2001; 2: 8–13.
2 Aukrust P, Ueland T, Lien E, and et al. Cytokine network in congestive heart
failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J
Cardiol 1999; 83: 376–382.
3 Testa M, Yeh M, Lee P, and et al. Circulating levels of cytokines and their
endogenous modulators in patients with mild to severe congestive heart
failure due to coronary artery disease or hypertension. J Am Col. Cardiol
1996; 28: 964–971.
4 Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL.doi: 10.3164/jcbn.10 129
©2011 JCBN
66
Proinflammatory cytokine levels in patients with depressed left ventricular
ejection fraction: a report from the Studies of Left Ventricular Dysfunction
(SOLVD). J Am Coll Cardiol 1996; 27: 1201–1206.
5 Kawakami H, Shigematsu Y, Ohtsuka T, and et al. Increased circulating
soluble form of Fas in patients with dilated cardiomyopathy. Jpn Circ J 1998;
62: 873–876.
6 Gullestad L, Aukrust P. Review of trials in chronic heart failure showing
broad-spectrum anti-inflammatory approaches. Am J Cardiol 2005; 95: C17–
C23.
7 Yndestad A, Damås JK, Øie E, Ueland T, Gullestad L, Aukrust P. Role of
inflammation in the progression of heart failure. Curr Cardiol Rep 2007; 9:
236–241.
8 Satoh M, Minami Y, Takahashi Y, Nakamura M. Immune modulation: role
of the inflammatory cytokine cascade in the failing human heart. Curr Heart
Fail Rep 2008; 5: 69–74.
9 Calder PC, Albers R, Antoine JM, and et al. Inflammatory disease processes
and interactions with nutrition. Br J Nutr 2009; 101 Suppl: S1–S45.
10 Chen YH, Lin SJ, Chen YL, Liu PL, Chen JW. Anti-inflammatory effects of
different drugs/agents with antioxidant property on endothelial expression of
adhesion molecules. Cardiovasc Hematol Disord Drug Targets 2006; 6: 279–
304.
11 Fischer CP, Hiscock NJ, Penkowa M, and et al. Supplementation with vitamins
C and E inhibits the release of interleukin-6 from contracting human skeletal
muscle. J Physiol 2004; 558 (Pt2): 633–645.
12 Sluijs I, Beulens JWJ, Grobbee DE, van der Schouw YT. Dietary carotenoid
intake is associated with lower prevalence of metabolic syndrome in middle-
aged and elderly men. J Nutr 2009; 139: 987–992.
13 Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res 2007; 55:
207–216.
14 Liu S, Ajani U, Chae C, Hennekens C, Buring JE, Manson JE. Longterm
beta-carotene supplementation and risk of type 2 diabetes mellitus: a
randomized controlled trial. JAMA 1999; 282: 1073–1075.
15 Wang L, Liu S, Manson JE, Gaziano JM, Buring JE, Sesso HD. The
consumption of lycopene and tomato-based food products is not associated
with the risk of type 2 diabetes in women. J Nutr 2006; 136: 620–625.
16 Wang G, Dai J, Mao J, Zeng X, Yang X, Wang X. Folic acid reverses hyper-
responsiveness of LPS-induced chemokine secretion from monocytes in
patients with hyperhomocysteinemia. Atherosclerosis 2005; 179: 395–402.
17 Witte KK, Nikitin NP, Parker AC, and et al. The effect of micronutrient
supplementation on quality-of-life and left ventricular function in elderly
patients with chronic heart failure. Eur Heart J 2005; 26: 2238–2244.
18 Shim JS, Oh KW, Suh I, and et al. A study on validity of a semiquantitative
food frequency questionnaire of Korean adults. Kor J Community Nutr 2002;
7: 484–494.
19 Lee YC, Lee HJ, Oh KW. Fatty acid composition of Korean foods. Seoul:
Shin Kwang Publisher, Inc., 1995.
20 Ministry of Health & Social Welfare, Republic of Korea. Korean food compo-
sition table. Seoul: Ministry of Health & Social Welfare, 1996.
21 National Rural Living Science Institute. Food composition table, 5th
Revision., 1996.
22 Rimm EB, Willett WC, Hu FB, and et al. Folate and vitamin B6 from diet
and supplements in relation to risk of coronary heart disease among women.
JAMA 1998; 279: 359–364.
23 Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT. Low dietary
folate intake is associated with an excess incidence of acute coronary events:
The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 2001;
103: 2674–2680.
24 Bazzano LA, He J, Ogden LG, and et al. Dietary intake of folate and risk of
stroke in US men and women: NHANES I Epidemiologic Follow-up Study:
National Health and Nutrition Examination Survey. Stroke 2002; 33: 1183–
1188.
25 Drogan D, Klipstein-Grobusch K, Dierkes J, Weikert C, Boeing H. Dietary
intake of folate equivalents and risk of myocardial infarction in the European
Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study.
Public Health Nutr 2006; 9: 465–471.
26 Solini A, Santini E, Ferrannini E. Effect of short-term folic acid supple-
mentation on insulin sensitivity and inflammatory markers in overweight
subjects. Int J Obes (Lond) 2006; 30: 1197–1202.
27 Title LM, Cummings PM, Giddens K, Genest JJ Jr., Nassar BA. Effect of
folic acid and antioxidant vitamins on endothelial dysfunction in patients with
coronary artery disease. J Am Coll Cardiol 2000; 36: 758–765.
28 Au-Yeung KK, Yip JC, Siow YL, O K. Folic acid inhibits homocysteine-
induced superoxide anion production and nuclear factor kappa B activation in
macrophages. Can J Physiol Pharmacol 2006; 84: 141–147.
29 Vasan RS, Beiser A, D’Agostino RB, and et al. Plasma homocysteine and
risk for congestive heart failure in adults without prior myocardial infarction.
JAMA 2003; 289: 1251–1257.
30 Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J.
Determinants of plasma total homocysteine concentration in the Framingham
Off-spring cohort. Am J Clin Nutr 2001; 73: 613–621.
31 Kennedy RH, Owings R, Shekhawat N, Joseph J. Acute negative inotropic
effects of homocysteine are mediated via the endothelium. Am J Physiol
Heart Cir Physiol 2004; 287: H812–H817.
32 Joseph J, Washington A, Joseph L, and et al. Hyperhomocysteinemia leads to
adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart Circ
Physiol 2002; 283: H2567–H2574.
33 Poddar R, Sivasubramanian N, Dibello PM, Robinson K, Jacobsen DW.
Homocysteine induces expression and secretion of monocyte chemoattractant
protein-1 and interleukin-8 in human aorticendothelial cells implications for
vascular disease. Circulation 2001; 103: 2717–2723.
34 Wang G, Siow YL, O K. Homocysteine induces monocyte chemoattractant
protein-1 expression by activating NF-κB in THP-1 macrophages. Am J
Physiol Heart Circ Physiol 2001; 280: H2840–2847.
35 van Aken, Jansen J, van Deventer SJ, Reitsma PH. Elevated levels of
homocysteine increase IL-6 production in monocytic Mono Mac 6 cells.
Blood Coagul Fibrinolysis 2000; 11: 159–164.
36 Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by
tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 2004;
24: 413–420.
37 Hyndman ME, Verma S, Rosenfeld RJ, Anderson TJ, Parsons HG.  Interac-
tion of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial
function. Am J Physiol Heart Circ Physiol 2002; 282: H2167–H2172.
38 Joshi R, Adhikari S, Patro BS, Chattopadhyay S, Mukherjee T. Free radical
scavenging behavior of folic acid: evidence for possible antioxidant activity.
Free Radic Biol Med 2001; 30: 1390–1399.
39 Stroes ES, van Faassen EE, Yo M, and et al. Folic acid reverts dysfunction of
endothelial nitric oxide synthase. Circ Res 2000; 86: 1129–1134.
40 Yu R, Kim CS, Kawada T, and et al. Involvement of leukotactin-1, a novel
CC chemokine, in human atherosclerosis. Atherosclerosis 2004; 174: 35–42.
41 Zozuliñska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka
B. Serum interleukin-8 level is increased in diabetic patients. Diabetologia
1999; 42: 117–118.
42 Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, Ferrer
J. Prognostic value of interleukin-8 as a predictor of heart failure in patients
with myocardial infarction and percutaneous intervention. Int J Cardiol 2006;
111: 158–160.
43 Friso S, Jacques PF, Wilson PW, Rosenberg IH, Selhub J. Low circulating
vitamin B(6) is associated with elevation of the inflammation marker C-
reactive protein independently of plasma homocysteine levels. Circulation
2001; 103: 2788–2791.
44 Folsom AR, Desvarieux M, Nieto FJ, Boland LL, Ballantyne CM, Chambless
LE. B vitamin status and inflammatory markers. Atherosclerosis 2003; 169:
169–174.
45 Dusitanond P, Eikelboom JW, Hankey GJ, and et al. Homocysteinelowering
treatment with folic acid, cobalamin, and pyridoxine does not reduce blood
markers of inflammation, endothelial dysfunction, or hypercoagulability in
patients with previous transient ischemic attack or stroke: a randomized
substudy of the VITATOPS trial. Stroke 2005; 36: 144–146.
46 Peeters AC, van Aken BE, Blom HJ, Reitsma PH, den Heijer M. The effect
of homocysteine reduction by B-vitamin supplementation on inflammatory
markers. Clin Chem Lab Med 2007; 45: 54–58.